Evidence map›Paper›PMID 40549000›Full record

ArticleUrologie (Heidelberg, Germany)2025

[Stones in the lower pole and their treatment].

F Abd Ali, P Vincze, T R W Herrmann, C Netsch, B Becker, G Hatiboglu, R Homberg, K Lehrich, A Miernik, P Olbert and 5 more

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Urologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

F Abd AliUniversitätsklinik für Urologie, UK-OWL, Campus Klinikum Lippe, Detmold, Deutschland.
P VinczeUniversitätsklinik für Urologie, UK-OWL, Campus Klinikum Lippe, Detmold, Deutschland.
T R W HerrmannUrologie, Kantonsspital Frauenfeld, Frauenfeld, Schweiz.
C NetschAbteilung für Urologie, Asklepios Klinik Barmbek, Hamburg, Deutschland.
B BeckerAbteilung für Urologie, Asklepios Klinik Barmbek, Hamburg, Deutschland.
G HatibogluKlinik für Urologie, SLK-Kliniken Heilbronn GmbH, Heilbronn, Deutschland.
R HombergKlinik für Urologie, Kinderurologie und Uro-Gynäkologie, St. Barbara-Klinik Hamm-Hessen, Hamm, Deutschland.
K LehrichKlinik für Urologie, Vivantes Auguste-Viktoria-Klinikum, Berlin, Deutschland.
A MiernikMedizinische Fakultät, Klinik für Urologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.
P OlbertBRIXSANA private clinic, Brixen, Italien.
D S SchöbMedizinische Fakultät, Klinik für Urologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.
J HerrmannKlinik für Urologie und Urochirurgie, Universitätsklinkum Mannheim, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Deutschland.
J A GrossAsklepios Klinik Barmbek, Hamburg, Deutschland.
L LusuardiUniversitätsklink für Urologie und Andrologie, Paracelsus Medizinische Universität Salzburg, Salzburg, Österreich.
Karl-Dietrich SievertUniversitätsklinik für Urologie, UK-OWL, Campus Klinikum Lippe, Röntgenstraße 18, 32756, Detmold, Deutschland. Karl-Dietrich.Sievert@uni-bielefeld.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most frequent initial clinical symptom is flank pain, which occurs in approximately half of affected patients with stones of the upper urinary tract. Of these patients approximately half require treatment and 50% will again have new stones in the future. Only 8% of urinary stones are clinically inapparent with 25-50% of the stones located in the lower calyx group and are incidentally discovered during the diagnostics of symptomatic stones. Stones in the lower calyx are more difficult to treat than other kidney stones due to the localization and the resulting access possibilities. The treatment must therefore be planned and carried out individually according to the available treatment options. Since the development of modern flexible ureterorenoscopes (URS) retrograde stone removal, which has few complications, has been highly valued in the treatment of stones of the lower calyx due to the desired primary stone clearance rates. Limiting factors are the longer treatment times for large stone masses and the considerable material costs. Furthermore, the various forms of percutaneous nephrolitholapaxy provide additional methods for the treatment of larger lower caliceal stones.

Indexed as

Kidney CalculiKidney CalicesHumansLithotripsyNephrolithotomy, PercutaneousNephrostomy, PercutaneousUreteroscopyExtracorporeal shock wave lithotripsyKidney calculiLower caliceal stonesStone clearance rateUreterorenoscopy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.